C‐reactive protein, delirium, and other psychological symptoms among patients with advanced cancer
JCSM Clinical Reports · 2020
DOI: 10.1002/crt2.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCSM Clinical Reports, 2020. Verfasst von Koji Amano und 12 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Delir
Abstract (Originalsprache)
Background
It remains unclear whether a relationship exists between elevated C‐reactive protein (CRP) levels and delirium. The primary aim was to investigate the relationship between CRP and delirium in advanced cancer.
Methods
This study was a multicenter prospective cohort study conducted in palliative care units. At baseline, the physicians diagnosed delirium. On the seventh day, they evaluated whether new delirium had occurred. Subjects were divided into four groups according to CRP levels. We assessed the associations between CRP levels and proportions of delirium. To evaluate the relationship between CRP and delirium, adjusted odd ratios (ORs) and 95% confidence intervals (CIs) were calculated in the logistic models.
Results
Among 1896 patients, 1354 patients were eligible for analyses. We classified them into four groups: low (CRP < 1 mg/dl) ( n = 170), moderate (1 ≤ CRP < 5 mg/dl) ( n = 453), high (5 ≤ CRP < 10 mg/dl) ( n = 334), and very high (10 mg/dl ≤ CRP) ( n = 397). The incidence of delirium significantly increased with increasing CRP levels ( P = 0.02). In model 1, significantly higher adjusted ORs than in the low CRP group were observed in the high CRP and very high CRP groups (1.63 [95% CI 1.06–2.50], P = 0.03; 1.72 [95% CI 1.13–2.62], P = 0.01, respectively). In model 2, a significantly higher adjusted OR than in the low CRP group was observed in the very high CRP group (1.61 [95% CI 1.05–2.45], P = 0.03).
Conclusions
Relationships existed between elevated CRP levels and delirium.
Zitieren
APA
Amano, K., Hatano, Y., Matsuda, Y., Maeda, I., Ishiki, H., Miura, T., Imai, K., Hori, T., Matsuda, Y., Funaki, H., Suzuki, K., Mori, M., & Morita, T. (2020). C‐reactive protein, delirium, and other psychological symptoms among patients with advanced cancer. JCSM Clinical Reports. https://doi.org/10.1002/crt2.12
Vancouver
Amano K, Hatano Y, Matsuda Y, Maeda I, Ishiki H, Miura T, et al. C‐reactive protein, delirium, and other psychological symptoms among patients with advanced cancer. JCSM Clinical Reports. 2020. doi:10.1002/crt2.12
BibTeX
@article{Amano2020,
author = {Amano, Koji and Hatano, Yutaka and Matsuda, Yoshinobu and Maeda, Isseki and Ishiki, Hiroto and Miura, Tomofumi and Imai, Kengo and Hori, Tetsuo and Matsuda, Yosuke and Funaki, Hiromi and Suzuki, Kozue and Mori, Masanori and Morita, Tatsuya},
title = {C‐reactive protein, delirium, and other psychological symptoms among patients with advanced cancer},
journal = {JCSM Clinical Reports},
year = {2020},
doi = {10.1002/crt2.12}
}
EUVIMED